Efficacy and safety of inhaled formoterol 4.5 and 9 μg twice daily in Japanese and European COPD patients: phase III study results
about
Long-acting beta2-agonists for chronic obstructive pulmonary diseaseLong-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysisInhaled Long-Acting β2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis.Differences in physical activity according to mMRC grade in patients with COPDLong-term outcomes in chronic obstructive pulmonary disease patients: exploring the effects of inhalatory devices and their influence on the outcome.
P2860
Efficacy and safety of inhaled formoterol 4.5 and 9 μg twice daily in Japanese and European COPD patients: phase III study results
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Efficacy and safety of inhaled ...... ients: phase III study results
@ast
Efficacy and safety of inhaled ...... ients: phase III study results
@en
Efficacy and safety of inhaled ...... ients: phase III study results
@nl
type
label
Efficacy and safety of inhaled ...... ients: phase III study results
@ast
Efficacy and safety of inhaled ...... ients: phase III study results
@en
Efficacy and safety of inhaled ...... ients: phase III study results
@nl
prefLabel
Efficacy and safety of inhaled ...... ients: phase III study results
@ast
Efficacy and safety of inhaled ...... ients: phase III study results
@en
Efficacy and safety of inhaled ...... ients: phase III study results
@nl
P2093
P2860
P356
P1476
Efficacy and safety of inhaled ...... ients: phase III study results
@en
P2093
Hisamichi Aizawa
Masaharu Nishimura
Masakazu Ichinose
Michiaki Mishima
Miron A Bogdan
Yoshinosuke Fukuchi
P2860
P2888
P356
10.1186/1471-2466-11-51
P577
2011-11-15T00:00:00Z
P5875
P6179
1016723559